• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Abbvie is making a name in hcv

Quote




































Rick doesn't need a degree, he has people all around him with great experience. Oh wait, did you know they promoted a guy to the head of Regulatory with NO regulatory experience - not one day! Commercial must want to start promoting off label and need a fall guy who won't ask questions because he doesn't know anything! Laughable. Can you say C-I-A?
 








Anonymous said:
I had a physician go to a program and he said to me later. Why in the hell would I use Vpack? Great feed back.
Click to expand...

Gotta love our KOL speakers. Our own worst enemies especially when an attendee asks an unsolicited question at a program. Something similar happened to me -- KOL said in front of the group when asked a VPak over Harvoni question that unless his hand is forced by the PBM and he's exhausted all other avenues then it's VPak but for his patients he prefers 1 pill QD.

Short of using silver duct tape on the audience, I can only control so much.
 




Anonymous said:
Gotta love our KOL speakers. Our own worst enemies especially when an attendee asks an unsolicited question at a program. Something similar happened to me -- KOL said in front of the group when asked a VPak over Harvoni question that unless his hand is forced by the PBM and he's exhausted all other avenues then it's VPak but for his patients he prefers 1 pill QD.

Short of using silver duct tape on the audience, I can only control so much.
Click to expand...

It happened to me as well. We might be selling more harvoni than gilead
 
















Top Bottom
Back
Quote